Press release
Lupus Nephritis Market Size Forecasted To Achieve $2.8 Billion By 2029 With Steady Growth
Lupus Nephritis Market Size
What Is the Lupus Nephritis Market Size and Projected Growth Rate?
The market for lupus nephritis has seen robust growth in the past few years and is predicted to expand from $1.94 billion in 2024 to $2.09 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.9%. The growth from the past period is primarily driven by increased investment in lupus nephritis research, a rise in the number of autoimmune disorders, increasing healthcare costs, a growing trend of biologics, and a rising interest in telemedicine.
Anticipations are high for a robust expansion of the lupus nephritis market in the coming years. The market is projected to escalate to $2.80 billion by 2029, with a compound annual growth rate (CAGR) of 7.6%. The growth expected in the forecast period can be credited to factors such as enhanced physician cognizance, rising acceptance of biologic treatments, growth in the number of specialized clinics, the heightened significance of kidney transplants, and enlarged accessibility to nephrology services. Notable trends anticipated during the forecast period encompass breakthroughs in biologic treatments, tailoring of medical treatments, innovative diagnostic biomarkers, wider involvement in clinical trials, and advancements in stem cell therapy methodologies.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22044
What Are the Major Segments in the Lupus Nephritis Market?
The lupus nephritis market covered in this report is segmented -
1) By Stage: Class 1, Class 2, Class 3, Other Stages
2) By Drug Class: Immunosuppressive Drugs, Corticosteroids, Biological Agents, Antimalarial Drugs
3) Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Class 1: Asymptomatic Cases, Mild Proteinuria, Incidental Diagnosis.
2) By Class 2: Mild Hematuria, Low-Grade Proteinuria, Minimal Immune Complex Deposition.
3) By Class 3: Active Lesions, Chronic Sclerotic Lesions, Crescent Formation.
4) By Other Stages: Class 4 (Diffuse Lupus Nephritis), Class 5 (Membranous Lupus Nephritis), Class 6 (Advanced Sclerotic Lupus Nephritis)
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22044&type=smp
What Are The Driving Lupus Nephritis Market Evolution?
The rise in the occurrence of genetic predisposition is projected to drive the expansion of the lupus nephritis market in the future. An individual's inherited genetic traits, which raise their chances of acquiring certain ailments or conditions, are what referred to as genetic predisposition. The growth in genetic predisposition prevalence can be attributed to factors such as inherited traits, environmental impacts, and mutations in designated genes. The rise in the occurrence of genetic predisposition has a crucial influence on the onset of lupus nephritis, accentuating the significance of hereditary genetic factors in autoimmune diseases, specifically those impacting renal function. For instance, the UK CF Registry, a project by the Cystic Fibrosis Trust, reported 11,148 registered patients in 2022, this number rose to 11,318 registered patients in October 2024, indicating a 1.52% growth in cystic fibrosis (CF) individuals. Hence, the rise in the occurrence of genetic predisposition is propelling the expansion of the lupus nephritis market.
Which Firms Dominate The Lupus Nephritis Market Segments?
Major companies operating in the lupus nephritis market are F. Hoffmann-La Roche Ltd., Bristol Myers Squibb, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Genentech, Astrazeneca PLC, Biocon Biologics, Hanmi Pharmaceutical Co. Ltd., Sana Biotechnology Inc., RemeGen Co. Ltd., Aurinia Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., Equillium Inc., Anthera Pharmaceuticals Inc., Atara Biotherapeutics Inc., Artiva Biotherapeutics, Caribou Biosciences, Nkarta Inc., Adicet Bio Inc., Lupus Research Alliance, Kyverna Therapeutics Inc., Kezar Life Sciences, Bionxt Solutions.
What Trends Are Expected to Dominate the Lupus Nephritis Market in the Next 5 Years?
A significant concentration of major firms involved in the lupus nephritis market is on the development of improved second-generation calcineurin inhibitors. These efforts aim at amplifying treatment success rates and elevating long-term kidney results for patients. Reduced inflammation and kidney damage prevention via immune response modulation are some of the benefits of these inhibitors within lupus nephritis treatment. For example, in September 2024, the Japanese Ministry of Health, Labour, and Welfare approved Aurinia Pharmaceuticals Inc.'s LUPKYNIS (voclosporin). This Canada-based commercial-stage biopharmaceutical company can now use voclosporin in combination with mycophenolate mofetil (MMF), following data from the AURORA Clinical Program that demonstrated its safety and efficacy. This approval is a considerable progressive step towards broadening lupus nephritis treatment alternatives in Japan, thereby enhancing disease management and outcomes.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/lupus-nephritis-global-market-report
Which Is The Largest Region In The Lupus Nephritis Market?
Asia-Pacific was the largest region in the lupus nephritis market in 2024. The regions covered in the lupus nephritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Lupus Nephritis Market?
2. What is the CAGR expected in the Lupus Nephritis Market?
3. What Are the Key Innovations Transforming the Lupus Nephritis Industry?
4. Which Region Is Leading the Lupus Nephritis Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lupus Nephritis Market Size Forecasted To Achieve $2.8 Billion By 2029 With Steady Growth here
News-ID: 3988308 • Views: …
More Releases from The Business Research Company
2025-2034 Anthracite Market Evolution: Disruptions, Innovations, and Untapped Op …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Anthracite Market Through 2025?
The size of the anthracite market has seen a slight increase in recent years. Its growth is projected to escalate from $130.76 billion in 2024 to $133.32 billion in 2025, indicating a compound annual growth rate (CAGR) of…
Global Arsenic Market Projected to Grow at 2% CAGR, Reaching $2.36 Billion by 20 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Arsenic Industry Market Size Be by 2025?
The market size for arsenic has seen a slight expansion in the past few years. The market is predicted to increase from $2.16 billion in 2024 to $2.18 billion in 2025, sustaining a compound annual growth rate (CAGR) of…
Intelligent Parcel Delivery Lockers Market Trends That Will Shape the Next Decad …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Intelligent Parcel Delivery Lockers Market Size By 2025?
Over the past few years, the market size for intelligent parcel delivery lockers has increased significantly. The market is predicted to expand from $1.14 billion in 2024 to $1.24 billion in 2025, with a compound annual growth…
Increasing Demand For Fuel-Efficient Vehicles Fueling The Growth Of The Market D …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Commercial Vehicle (CV) Active Power Steering Market Size Growth Forecast: What to Expect by 2025?
Recent years have seen a robust expansion in the commercial vehicle (cv) active power steering market. The market, which stood at $5.28 billion in 2024, is predicted to reach $5.71 billion in 2025, marking…
More Releases for Lupus
Cutaneous Lupus Erythematosus (CLE) Market
Introduction
Cutaneous Lupus Erythematosus (CLE) is a chronic autoimmune skin disorder, often associated with systemic lupus erythematosus (SLE), that presents as inflammation, rashes, and photosensitivity. While CLE is rarely fatal, it significantly affects patients' physical and emotional well-being, often leading to scarring, disfigurement, and social stigma.
Over the past decade, the market for CLE therapies has gained global importance as research into autoimmunity has accelerated and biologic therapies have transformed dermatology. Rising…
Prominent Cutaneous Lupus Erythematosus Market Trend for 2025: Advancements In C …
What combination of drivers is leading to accelerated growth in the cutaneous lupus erythematosus market?
The rising prevalence of skin infections is expected to drive the growth of the cutaneous lupus erythematosus (CLE) market. Skin infections are caused by microorganisms that invade the skin, triggering immune responses that can worsen symptoms in individuals with CLE. For example, the UK saw a 33.7% increase in MRSA cases caused by skin and soft…
Cutaneous Lupus Erythematosus (CLE) Market
Market Overview:
The Global Cutaneous Lupus Erythematosus (CLE) Market is forecasted to achieve a High CAGR during the period 2023-2030. CLE encompasses a spectrum of dermatological symptoms that may precede or accompany systemic lupus erythematosus (SLE), an autoimmune condition impacting multiple organs. Timely diagnosis and treatment of CLE can prevent the onset of severe systemic symptoms.
Market Dynamics:
Drivers:
Rise in Clinical Studies: Technological advancements leading to faster and accurate diagnosis have spurred additional…
Lupus Nephritis Treatment Market 2030
Global Lupus Nephritis Treatment market is expected to be worth roughly USD 8,048 million by 2030, growing at a CAGR of 7.3% during the forthcoming period of 2022-2030, according to Ameco Research
Lupus nephritis is one of the most rapidly spreading diseases over the globe. The increasing frequency of lupus nephritis and consumer awareness has fuelled the worldwide lupus nephritis treatment market. Another crucial factor driving the pace of growth of…
Lupus Erythematosus Market -API Insights, 2017
Summary
Orbis Research Present “Lupus Erythematosus-API Insights, 2017”
Description
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.
India and China produce a large percentage…
Global Systemic Lupus Erythematosus and Lupus Nephritis Market to Display 10.6% …
"The Report PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
MarketResearchReports.biz has announced the addition of a new report, titled “PharmaPoint: Systemic Lupus Erythematosus And Lupus Nephritis - Global Drug Forecast And Market Analysis To 2025,” to its expanding repository of research reports. The market…
